Navigating EU Challenges: Strategies for Biological Companies to Succeed

Launching biological products in the EU faces significant hurdles, primarily due to a complex regulatory system and market fragmentation. Challenges include slow microbial approvals, the need for tailored solutions, farmer education, and demonstrating sustainability benefits.  

Companies must address issues like high production costs, product stability, and fierce competition. Learn what AgriBusiness Global found out from Mark Trimmer, President and Founding Partner of DunhamTrimmer, Thomas Laurant, CEO of Micropep, and Lawrence Middler, Biologicals Senior Analyst for AgbioInvestor, about addressing these key challenges in a recent issue of AgriBusiness Global DIRECT. 

Hide picture